Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)
China flag China · Delayed Price · Currency is CNY
107.60
-2.55 (-2.32%)
Sep 26, 2025, 2:45 PM CST
-2.32%
Market Cap48.30B
Revenue (ttm)4.36B
Net Income (ttm)1.82B
Shares Out450.00M
EPS (ttm)4.06
PE Ratio26.44
Forward PE26.37
Dividend0.80 (0.75%)
Ex-Dividend DateSep 10, 2025
Volume3,898,710
Average Volume6,637,252
Open109.05
Previous Close110.15
Day's Range106.90 - 109.50
52-Week Range41.01 - 122.20
Beta0.53
RSI49.74
Earnings DateOct 24, 2025

About SHA:688578

Shanghai Allist Pharmaceuticals Co., Ltd., a pharmaceutical company, engages in the research and development of tumor-targeted drugs in China. Its lead product is vometinib mesylate tablet for the treatment of patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer (NSCLC), as well as for treating adult patients with locally advanced or metastatic NSCLC. The company was founded in 2004 and is based in Shanghai, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Employees 1,417
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688578
Full Company Profile

Financial Performance

In 2024, SHA:688578's revenue was 3.56 billion, an increase of 76.29% compared to the previous year's 2.02 billion. Earnings were 1.43 billion, an increase of 121.97%.

Financial Statements

News

There is no news available yet.